智通港股股东权益披露|8月25日

Group 1 - The latest shareholder equity disclosure for Yuan Da Pharmaceutical (00512) and Hongxin Jianda (09930) was conducted on August 25, 2025 [1] - Yuan Da Pharmaceutical saw an increase in shares held by Zhou Chao from 407,000 shares to 452,500 shares, maintaining a holding percentage of 0.01% [2] - Hongxin Jianda experienced an increase in shares held by Zhan Jing from 15,428,200 shares to 15,928,200 shares, with a holding percentage of 0.49% [2]